Gents ,

During year 2007 the U.S. Food and Drug Administration (FDA) announced that the medicine Avandia (rosiglitazone), a drug used to treat type 2 diabetes might cause heart attack; but the manufacturer company (Glaxo) opposed that announcement at that time. But this week the FDA issued a revised version of a FDA Press Release, originally issued November 14, 2007.
Revisions have been made to correct the title from "Heart Attacks to Heart-related Risk.

So patients who are using this medicine should revisit their doctor to discuss that subject with them.



http://www.fda.gov/NewsEvents/Newsro.../ucm109026.htm



http://www.nytimes.com/2010/02/20/he...20avandia.html